부가기능
Pathophysiologic and impairment outcomes in a randomized control trial of botulinum toxin type A for children with spastic diplegic cerebral palsy. Ross Hays, MD (Children's Hospital & Regional Medical Center, Seattle, WA); Kristie F. Bjornson, MS, PT; C/
기사 상세정보
서평
서평등록 중 오류가 발생하였습니다. 재시도 하십시오.